Gamunex-c 40 gram/400 ML vial 400ML
Ended Awarded
- Contract number
- SPE2DB25FAYA4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,272
Award facts
- Contract value 100% obligated
- $23,272.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,272 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Gamunex-C 40 gram/400 mL vials. The contract, which is not set-aside and employs firm fixed pricing, is scheduled for completion by June 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026, which serves as a comprehensive vehicle for pharmaceutical and medical supply procurement supporting global military healthcare operations.
As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp maintains an extensive portfolio of competitively awarded contracts with the Defense Logistics Agency and Medical Supply Chain. The company supplies a comprehensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Gamunex-C, an intravenous immunoglobulin product used in treating immunodeficiency conditions, represents a routine pharmaceutical supply transaction consistent with the company's primary federal contracting mission.
Quick answers
Who was awarded contract SPE2DB25FAYA4?
SPE2DB25FAYA4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FAYA4 worth?
The government has obligated $23,272 on SPE2DB25FAYA4.
Is contract SPE2DB25FAYA4 an order under another contract?
Yes. SPE2DB25FAYA4 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FAYA4 competed?
The extent of competition for SPE2DB25FAYA4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award